{"entity":{"type":"insider","cik":"0001799357","url":"/insider/0001799357","json_url":"/insider/0001799357.json","name":"Hassard James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2021-01-08","last":"2024-07-09","span_basis":"filed_date"},"name_variants":[{"name":"Hassard James","source":"filing","n_filings":4,"first_seen":"2021-01-08","last_seen":"2024-07-09"}],"transactions":[{"id":2177412,"accession":"0000950170-24-082529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-082529","line_url":"/filing/0000950170-24-082529#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001799357","owner_name":"Hassard James","owner_display_name":"Hassard James","owner_url":"/insider/0001799357","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":44.08,"price_display":"44.08","price_state":"stated","total_value":661200.0,"total_display":"661,200.00","total_whole":"661,200","shares_owned_after":29259.0,"shares_owned_after_display":"29,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-09","scope":"insider"},{"id":2851090,"accession":"0000950170-24-076871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-076871","line_url":"/filing/0000950170-24-076871#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001799357","owner_name":"Hassard James","owner_display_name":"Hassard James","owner_url":"/insider/0001799357","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":44.66,"price_display":"44.66","price_state":"stated","total_value":669900.0,"total_display":"669,900.00","total_whole":"669,900","shares_owned_after":29259.0,"shares_owned_after_display":"29,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-21","filed_date":"2024-06-24","scope":"insider"},{"id":4339771,"accession":"0001209191-21-043137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-043137","line_url":"/filing/0001209191-21-043137#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001799357","owner_name":"Hassard James","owner_display_name":"Hassard James","owner_url":"/insider/0001799357","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3625.0,"shares_display":"3,625","price_per_share":89.22,"price_display":"89.22","price_state":"stated","total_value":323422.5,"total_display":"323,422.50","total_whole":"323,423","shares_owned_after":105750.0,"shares_owned_after_display":"105,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-24","scope":"insider"},{"id":5144086,"accession":"0001209191-21-002801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-002801","line_url":"/filing/0001209191-21-002801#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001799357","owner_name":"Hassard James","owner_display_name":"Hassard James","owner_url":"/insider/0001799357","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15625.0,"shares_display":"15,625","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":1171875.0,"total_display":"1,171,875.00","total_whole":"1,171,875","shares_owned_after":109375.0,"shares_owned_after_display":"109,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001658247","name":"Crinetics Pharmaceuticals, Inc.","url":"/issuer/0001658247","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2024-06-24","last_seen":"2024-07-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2021-01-08","last_seen":"2021-06-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001799357","retrieved_at":"2026-08-22T12:27:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}